Register
Clinical News
eMediNexus Coverage from: 
Little Difference with Oral Semaglutide vs Liraglutide in Diabetes
eMediNexus,  12 June 2019
remove_red_eye 584 Views
#Diabetes and Endocrinology #Hospital Medicine #Internal Medicine #Pharmacist

1 Read Comments                

Oral semaglutide, an investigational agent, is noninferior to subcutaneous liraglutide in reducing HbA1c in patients with type 2 diabetes and superior in terms of weight loss, show results of the PIONEER 4 trial, the first study to compare the efficacy and safety of this form of semaglutide with liraglutide. The results were reported at the American Diabetes Association (ADA) 2019 Scientific Sessions.Also presented in a poster were findings from PIONEER 7, which compa
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!